Enliven Therapeutics, Inc (ELVN) Tops Q3 EPS by 18c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q3 EPS of ($0.32), $0.18 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Nuscale Power (SMR) PT Lowered to $15 at B.Riley